ABC1: connecting yellow tonsils, neuropathy, and very low HDL
Open Access
- 15 October 1999
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (8) , 1015-1017
- https://doi.org/10.1172/jci8509
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathwayJournal of Clinical Investigation, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Molecular Cloning of the Human ATP-Binding Cassette Transporter 1 (hABC1): Evidence for Sterol-Dependent Regulation in MacrophagesBiochemical and Biophysical Research Communications, 1999
- Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.Journal of Clinical Investigation, 1995
- Homozygous Tangier disease and cardiovascular diseaseAtherosclerosis, 1994
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Pathology of roots, spinal cord and brainstem in syringomyelia-like syndrome of Tangier diseaseJournal of the Neurological Sciences, 1991
- LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in AtherosclerosisAnnual Review of Biochemistry, 1983
- Tangier DiseaseNew England Journal of Medicine, 1978
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974